Free Trial

Vera Therapeutics (VERA) Earnings Date, Estimates & Call Transcripts

$41.64
+1.31 (+3.25%)
(As of 12:46 PM ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 14Estimated
Actual EPS
(Aug. 8)
-$0.62 Missed By -$0.06
Consensus EPS
(Aug. 8)
-$0.56
Skip Charts & View Estimated and Actual Earnings Data

VERA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VERA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Vera Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.61)($0.46)($0.54)
Q2 20243($0.65)($0.49)($0.57)
Q3 20243($0.67)($0.51)($0.59)
Q4 20243($0.75)($0.52)($0.64)
FY 202411($2.68)($1.98)($2.33)

VERA Earnings Date and Information

Vera Therapeutics last posted its quarterly earnings results on August 8th, 2024. The reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.56) by $0.06. Vera Therapeutics has generated ($2.05) earnings per share over the last year (($2.05) diluted earnings per share). Earnings for Vera Therapeutics are expected to decrease in the coming year, from ($2.57) to ($2.85) per share. Vera Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off prior year's report dates.

Vera Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/14/2024
(Estimated)
------- 
8/8/2024Q2 2024($0.56)($0.62)($0.06)($0.62)--  
5/9/2024Q1 2024($0.53)($0.56)($0.03)($0.56)--  
3/20/2024Q4 2023($0.53)($0.58)($0.05)($0.58)--  
11/9/2023Q3 2023($0.50)($0.45)+$0.05($0.45)--  
8/10/2023Q2 2023($0.69)($0.46)+$0.23($0.46)--  
5/11/2023Q1 2023($0.59)($0.80)($0.21)($0.80)--  
This Crypto Is Set to Explode in September (Ad)

With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024.

Go here to get full details on this crypto now.
3/28/2023Q4 2022($0.93)($1.19)($0.26)($1.19)--  
11/9/2022Q3 2022($0.72)($0.91)($0.19)($0.91)--  
8/10/2022Q2 2022($0.72)($0.55)+$0.17($0.55)--  
5/16/2022Q1 2022($0.67)($0.71)($0.04)($0.71)--  
3/24/2022Q4 2021($0.49)($0.79)($0.30)($0.79)--  
11/10/2021Q3 2021($0.69)($0.36)+$0.33($0.36)--  
8/16/2021Q2 2021($0.39)($0.33)+$0.06($0.33)--  
6/23/2021Q1 2021($1.94)($12.23)($10.29)($12.23)--  

Vera Therapeutics Earnings - Frequently Asked Questions

When is Vera Therapeutics's earnings date?

Vera Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on VERA's earnings history.

Did Vera Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Vera Therapeutics (NASDAQ:VERA) missed the analysts' consensus estimate of ($0.56) by $0.06 with a reported earnings per share (EPS) of ($0.62). Learn more on analysts' earnings estimate vs. VERA's actual earnings.

How much profit does Vera Therapeutics generate each year?

Vera Therapeutics (NASDAQ:VERA) has a recorded net income of -$95.99 million. VERA has generated -$2.05 earnings per share over the last four quarters.

What is Vera Therapeutics's EPS forecast for next year?

Vera Therapeutics's earnings are expected to decrease from ($2.57) per share to ($2.85) per share in the next year.


More Earnings Resources from MarketBeat


This page (NASDAQ:VERA) was last updated on 9/19/2024 by MarketBeat.com Staff
From Our Partners